What is BRASH (Bradycardia, Renal failure, Av-block, Shock, and Hyperkalemia) Syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

BRASH syndrome is a life-threatening condition that requires immediate medical attention with a multi-faceted treatment approach, prioritizing the management of hyperkalemia, renal dysfunction, and AV nodal blockade to prevent morbidity, mortality, and improve quality of life. The syndrome is characterized by Bradycardia, Renal failure, AV nodal blockade, Shock, and Hyperkalemia, and its management differs from the standard bradycardia algorithm in advanced cardiac life support (ACLS) 1. Initial management includes calcium gluconate (1-2 grams IV) to stabilize cardiac membranes, insulin (10 units regular insulin IV with 25g dextrose) and sodium bicarbonate (50-100 mEq IV) to shift potassium intracellularly, and diuretics or dialysis for potassium removal 2, 3, 4. Vasopressors like norepinephrine may be needed for hypotension, and temporary cardiac pacing might be required for severe bradycardia. The syndrome occurs through a dangerous synergistic interaction between hyperkalemia, renal dysfunction, and medications that affect the AV node (like beta-blockers or calcium channel blockers), creating a vicious cycle where hyperkalemia worsens bradycardia, reduced cardiac output impairs renal function, and kidney injury leads to medication accumulation and worsening hyperkalemia 5.

Key Considerations

  • Patients with chronic kidney disease taking AV nodal blocking medications are particularly susceptible to BRASH syndrome 2, 3, 4
  • The prognosis of BRASH syndrome is excellent with timely recognition and management 1, 5
  • A medication review, particularly of cardiac medications, including AV nodal blocking agents, is critical for diagnosing BRASH syndrome 1
  • The management principles of BRASH syndrome are conservative management, addressing the precipitating event or medications, and correcting electrolyte derangements 1

Treatment Approach

  • Initial management: calcium gluconate, insulin, and sodium bicarbonate to stabilize cardiac membranes and shift potassium intracellularly
  • Diuretics or dialysis for potassium removal
  • Vasopressors like norepinephrine for hypotension
  • Temporary cardiac pacing for severe bradycardia
  • Addressing underlying causes and adjusting medications to prevent recurrence 2, 3, 4, 1, 5

References

Research

Two Cases of BRASH Syndrome: A Diagnostic Challenge.

European journal of case reports in internal medicine, 2022

Research

BRASH syndrome.

BMJ case reports, 2020

Research

The BRASH syndrome, a synergistic arrhythmia phenomenon.

Proceedings (Baylor University. Medical Center), 2020

Research

BRASH Syndrome: A Case Report.

The Journal of emergency medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.